SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD. Quality of life in stoma patients. Dis Colon Rectum. 1999; 42: 1569-1574.
  • 2
    Oberst MT, Scott DW. Postdischarge distress in surgically treated cancer patients and their spouses. Res Nursing Health. 1988; 11: 223-233.
  • 3
    Silva MA, Ratnayake G, Deen KI. Quality of life of stoma patients: temporary ileostomy versus colostomy. World J Surg. 2003; 27: 421-424.
  • 4
    Guren MG, Dueland S, Skovlund E, Fossa SD, Poulsen JP, Tveit KM. Quality of life during radiotherapy for rectal cancer. Eur J Cancer. 2003; 39: 587-594.
  • 5
    Camilleri-Brennan J, Steele RJC. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg. 2001; 88: 1617-1622.
  • 6
    Camilleri-Brennan J, Steele RJC. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol. 2001; 27: 349-353.
  • 7
    Schag CA, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 1994; 3: 127-141.
  • 8
    Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10: 19-28.
  • 9
    Barsevick AM, Pasacreta J, Orsi A. Psychological distress and functional dependency in colorectal cancer patients. Cancer Pract. 1995; 3: 105-110.
  • 10
    Stark D, Kiely M, Smith A, Velikova F, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002; 20: 3137-3148.
  • 11
    Karadag A, Mentes BB, Uner A, Irkkorucu O, Ayaz S, Ozkan S. Impact of stomatherapy on quality of life in patients with permanent colostomies or ileostomies. Int J Colorectal Dis. 2003; 18: 234-238.
  • 12
    Little M, Jordens CFC, Paul K, Montgomery K, Philipson B. Liminality: A major category of the experience of cancer illness. Soc Sci Med. 1998; 47: 1485-1494.
  • 13
    Little M, Jordens CFC, Paul K, Sayers E, Sriskandarajah D. Face, honor and dignity in the context of colon cancer. J Med Humanit. 2000; 21: 229-243.
  • 14
    Lepore SJ, Silver RC, Wortman CB, Wayment HA. Social constraints, intrusive thoughts, and depressive symptoms among bereaved mothers. J Pers Soc Psychol. 1996; 70: 271-282.
  • 15
    Pennebaker JW, Kiecolt-Glaser JK, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol. 1988; 56: 239-245.
  • 16
    Pennebaker JW. Writing about emotional experiences as a therapeutic process. Psychol Sci. 1997; 8: 162-166.
    Direct Link:
  • 17
    Esterling BA, L'Abate L, Murray EJ, Pennebaker JW. Empirical foundations for writing in prevention and psychotherapy: mental and physical outcomes. Clin Psychol Rev. 1999; 19: 79-96.
  • 18
    Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol. 1998; 66: 174-184.
  • 19
    Lepore SJ, Greenberg MA, Bruon M, Smyth JM. Expressive writing and health: self-regulation of emotion-related experience, physiology, and behavior. In: Lepore SJ, Smyth JM, eds. The Writing Cure: How Expressive Writing Promotes Health and Emotional Well-Being. Washington, DC: American Psychological Association; 2002: 99-117.
  • 20
    Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006; 132: 823-865.
  • 21
    Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis. JAMA. 1999; 281: 1304-1309.
  • 22
    Klapow JC, Schmidt SM, Taylor LA, et al. Symptom management in older primary care patients: feasibility of an experimental, written self-disclosure protocol. Ann Intern Med. 2001; 134: 905-911.
  • 23
    Stanton AL, Danoff-Burg S. Emotional expression, expressive writing, and cancer. In: Lepore SJ, Smyth JM, eds. The Writing Cure: How Expressive Writing Promotes Health and Emotional Well-Being. Washington, DC: American Psychological Association; 2002: 31-51.
  • 24
    Walker BL, Nail LM, Croyle RT. Does emotional expression make a difference in reactions to breast cancer? Oncol Nurs Forum. 1999; 26: 1025-1032.
  • 25
    Gellaitry G, Peters K, Bloomfield D, Horne R. Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer. Psychooncology. 2010; 19: 77-84.
  • 26
    de Moor JS, Moye L, Low MD, et al. Expressive writing as a presurgical stress management intervention for breast cancer patients. J Soc Integr Oncol. 2008; 6: 59-66.
  • 27
    Pennebaker JW, Colder M, Sharp LK. Accelerating the coping process. J Pers Soc Psychol. 1990; 58: 528-537.
  • 28
    Stanton AL, Danoff-Burg S, Sworowski LA, et al. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol. 2002; 20: 4160-4168.
  • 29
    Lutgendorf SK, Antoni MH. Emotional and cognitive processing in a trauma disclosure paradigm. Cognit Ther Res. 1999; 23: 423-440.
  • 30
    Lepore SJ, Ragan JD, Jones S. Talking facilitates cognitive-emotional processes of adaptation to an acute stressor. J Pers Soc Psychol. 2000; 78: 499-508.
  • 31
    Paulus PB. Group processes in therapeutic support groups. In: Baum A, Andersen BL, eds. Psychosocial Interventions for Cancer. Washington, DC: American Psychological Association; 2001: 131-141.
  • 32
    Derogatis LR. Brief Symptom Inventory: Administration, Scoring and Procedures Manual. 3rd ed. Minneapolis, MN: National Computer Systems; 1993.
  • 33
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13: 595-605.
  • 34
    Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. ed. 3rd ed. New York, NY: Springer-Verlag; 1998.
  • 35
    Pocock SJ. Clinical Trials: A Practical Approach. New York, NY: John Wiley & Sons; 1983.
  • 36
    Therneau TM. How many stratification factors are “too many” to use in a randomization plan? Control Clin Trials. 1993; 14: 98-108.
  • 37
    Ullrich PM, Lutgendorf SK. Journaling about stressful events: effects of cognitive processing and emotional expression. Ann Behav Med. 2002; 24: 244-250.
  • 38
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.
  • 39
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-376.
  • 40
    Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41: 209-218.
  • 41
    Epping-Jordon JE, Compas BE, Osowiecki DM, et al. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol. 1999; 18: 315-326.
  • 42
    Kendall PC, Howard BL, Hays RC. Self-referent speech and psychopathology: the balance of positive and negative thinking. Cognit Ther Res. 1989; 13: 583-598.
  • 43
    Hollen SD, Kendall PC. Cognitive self-statements in depression: development of an automatic thoughts questionnaire. Cognit Ther Res. 1980; 4: 383-395.
  • 44
    Carver C, Scheier M, Weintraub J. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989; 56: 267-283.
  • 45
    Cohen S, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR, eds. Social Support: Theory, Research, and Application. The Hague, Holland: Martinus Nijhoff; 1985: 73-94.
  • 46
    Cohen S, Willis TA. Stress, social support and the buffering hypothesis. Psychol Bull. 1985; 98: 310-357.
  • 47
    Schag CA, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System-Short Form (CARES-SF): a cancer specific rehabilitation and quality of life instrument. Cancer. 1991; 68: 1406-1413.
  • 48
    Lepore SJ, Helgeson V. Social constraints, intrusive thoughts, and mental health in prostate cancer survivors. J Soc Clin Psychol. 1998; 17: 89-106.
  • 49
    Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51: 1173-1182.
  • 50
    Lepore SJ. A social-cognitive processing model of emotional adjustment to cancer. In: Baum A, Andersen BL, eds. Psychosocial Interventions for Cancer. Washington, DC: American Psychological Association; 2001: 99-116.
  • 51
    Helgeson VS, Cohen S, Schulz R, Yasko J. Group support interventions for women with breast cancer: who benefits from what? Health Psychol. 2000; 19: 107-114.
  • 52
    Sloan DM, Marx BP, Epstein EM, Dobbs JL. Expressive writing buffers against maladaptive rumination. Emotion. 2008; 8: 302-306.
  • 53
    Baranowski T, Anderson C, Carmack CL. Mediating variable framework in physical activity intervention: How are we doing? How might we do better? Am J Prev Med. 1998; 15: 266-297.